Offerings // Travere Therapeutics, Inc.

TVTX offering history

Every offering-related filing in Travere Therapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,001 filings back to Apr 2, 2015.

Last executed offering
May 11, 2026
8-K — priced deal (shares or notes)
Last registration (announced)
Aug 1, 2024
S-3ASR — capacity, not a sale
Executed, last 12 months
3
424B pricings + 8-K 3.02 sales
Registered, last 12 months
0
S-1/S-3/F-series registrations
DateFilingWhat it means
May 11, 20268-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 7, 2026FWPMARKETINGFree-writing prospectus — offering being marketed
May 7, 2026424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 5, 2026424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 8, 2024424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 7, 2024424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 31, 2024424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 1, 2024S-3ASRREGISTEREDAutomatic shelf registration — effective immediately (large filers)
Mar 1, 2023FWPMARKETINGFree-writing prospectus — offering being marketed
Mar 1, 2023424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 27, 2023424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 9, 2022FWPMARKETINGFree-writing prospectus — offering being marketed
Mar 9, 2022FWPMARKETINGFree-writing prospectus — offering being marketed
Mar 9, 2022424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 8, 2022424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 3, 2021S-3ASRREGISTEREDAutomatic shelf registration — effective immediately (large filers)
Feb 12, 2021424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 10, 2021424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 9, 2020424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 8, 2020424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 24, 2020424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 6, 2018FWPMARKETINGFree-writing prospectus — offering being marketed
Sep 6, 2018424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 4, 2018S-3ASRREGISTEREDAutomatic shelf registration — effective immediately (large filers)
Sep 4, 2018424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 6, 20158-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
TVTX offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full TVTX workspace →
TVTX offering FAQ

When did TVTX last execute an offering?

Per SEC filings, Travere Therapeutics, Inc.'s most recent priced offering document is a 8-K filed 2026-05-11. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did TVTX last announce or register an offering?

The most recent registration is a S-3ASR filed 2024-08-01. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.